The demand for bariatric operations dropped sharply last year as use of anti-obesity drugs such as Wegovy surged, study finds ...

These include commonly prescribed drugs such as Ozempic or Wegovy (semaglutide), Saxenda (liraglutide), Zepbound (tirzepatide ...

Expiry of Novo Nordisk’s UK patent for Saxenda seen as offering a ‘dry run’ for future generic versions of Ozempic ...

As for why it’s not approved for weight loss in the UK, Dr Kayat added: “It works by helping to regulate your appetite and ...

India’s powerful copycat pharmaceutical industry is set to roll out generic weight loss drugs in the U.K. within weeks ...

In a much-anticipated release, the Congressional Budget Office (CBO) published projections estimating it would cost Medicare ...

a new study shows Ozempic produced 10% or more weight loss in 61% of obese people compared with 29% for Saxenda ...

Newer weight loss drugs are cost effective in the long term only when combined with bariatric weight loss surgery, according ...

Health secretary Wes Streeting announced weight loss injections could be used to get people living with obesity "back to work ...

One of the downsides of treatments such as Ozempic or Mounjaro is that even though patients wind up losing weight, they also tend to shed muscle mass. Losing too much muscle mass can be a health risk ...